Skip navigation
Agenda

The World’s Largest and Highest Acclaimed Life Sciences Event for CFOs, Controllers and Finance Executives

March 20-22, 2019
  • Philadelphia, PA

Agenda

Want more agenda details? Download the brochure.

DAY ONE WEDNESDAY, MARCH 20, 2019

9:00

Pre-Congress Registration

10:00 CHOOSE FROM 3 PRE-CONGRESS BREAKOUT SESSIONS (I-III)

I 101 Boot Camp

Michael Lombardo
Partner
Deloitte & Touche LLP

II New Product Commercialization/ Launch Strategies

Graham Poles
Partner
PwC

Zachary Weisbly
Director
PwC

Manmeet S. Soni
Chief Financial Officer
Alnylam Pharmaceuticals, Inc.

Chris Prentiss
Chief Accounting Officer
Adamas Pharmaceuticals, Inc.

III Industry-Only Roundtable Session

Nancy Stempin
Executive Director, Financial Accounting Advisory Services
Ernst & Young LLP

10:45

Networking and Refreshment Break

12:00

General Registration

1:00 CHOOSE BETWEEN 2 NETWORKING SUMMITS (A-B)

A Newcomer’s Orientation and Welcome Summit

SUMMIT DISCUSSION LEADERS:

James D’Arreca
Senior Vice President and Chief Accounting Officer
Allergan plc

Robert Owens
Vice President and Chief Accountant
BMS

Stephen Rivera
Vice President, Global Technical Accounting Advisory Services and Policy
Johnson & Johnson

B Women’s Leadership Summit

SUMMIT DISCUSSION LEADERS:

Laura Robinette
US Pharmaceutical and Life Sciences Assurance Leader
PwC

Toni Lockett Cromwell
Partner
PwC

DISCUSSION CONTRIBUTORS:

Gisele Dion
Senior Vice President, Chief Accounting Officer and Controller
Shire

Jill McConnell
Chief Financial Officer
Covance

Cynthia Schwalm
retired CEO, Ipsen;
current Biotech Board Member

Jennifer Ziolkowski
Chief Financial Officer
Solid Biosciences

2:00

Networking and Refreshment Break

GENERAL SESSION

2:30

Chairperson’s Welcoming Remarks

Cathy Engelbert
CEO
Deloitte

2:45

CEO Fireside Chat — Candid Conversation on Key Business and Industry Topics

Cathy Engelbert
CEO
Deloitte

Heather Bresch
CEO
Mylan

3:30

CFO KEYNOTE PANELLeading in Finance and Navigating the Course of Change

MODERATOR:

Laura Robinette
US Pharmaceutical and Life Sciences Assurance Leader
PwC

PANELISTS:

Blaise Coleman
Chief Financial Officer
Endo

Bryan Reasons
Chief Financial Officer
Impax Labs/Amneal

Paolo Tombesi
Chief Financial Officer
Insmed Incorporated

Mark W Hahn
Chief Financial Officer
Dova Pharmaceuticals, Inc.

4:30

REGULATORY INSIGHTS PANEL Making Strides in the Relevance and Effectiveness of Financial Reporting

MODERATOR:

Christine Davine
Partner and National Director of SEC Services
Deloitte & Touche LLP

PANELISTS:

James G. Kaiser
Board Member
PCAOB

Sagar Teotia
Deputy Chief Accountant
U.S. Securities and Exchange Commission

5:15

Industry Spotlight —
SEC Insights and Comment Letter Reviews of Life Science and Health Companies

James Rosenberg
Senior Assistant Chief Accountant, Office of Health Care and Insurance
U.S. Securities and Exchange Commission

Christine Davine
Partner and National Director of SEC Services
Deloitte & Touche LLP

5:40

Close of Day One

JOIN US FOR THE OPENING NIGHT WELCOME RECEPTION immediately following the final session on day one HOSTED BY: Ernst & Young

DAY TWO THURSDAY, MARCH 21, 2019

6:00

“Rocky Run”   Hosted by: PwC

Join PwC and industry colleagues in a morning “Rocky Run”. Participants depart the hotel at 6am and run just under 2 miles to the Philadelphia Art Museum, ascending the famous Rocky Steps and taking a photo with Rocky’s statue. Do not miss this traditional Philadelphia right of passage! Return transportation provided.

7:00

Breakfast

8:00

Co-Chairs’ Welcome and Opening Remarks

Jeff Ellis
Partner, U.S. Life Sciences and Healthcare Audit Leader
Deloitte & Touche LLP

8:15

WALL STREET AND INVESTMENT PANELImpactful Deals and Breakthroughs Impacting the Life Science Marketplace

MODERATER:

Pamela Yanakopulos
Partner, Capital Market and Accounting Advisory
PwC

PANELISTS:

Tony Gibney
Executive Vice President and Chief Business Officer
Achillion Pharmaceuticals, Inc.

Jeffrey Schwartz
Managing Director, Life Sciences
Bain Capital

Speaker to be announced
Bank of America Merrill Lynch

9:00

Pricing, Reimbursement and Outcomes-Based Contracting Models —
An Inflection Point of Change for Today’s Life Science Landscape

Susan Garfield
Global Advisory Principal and Life Sciences Sector Commercial Lead
Ernst & Young LLP

Sasha Richardson
Executive Director – Advisory Lifesciences, Commercial Strategy
Ernst & Young LLP

9:40

Value-Based Healthcare and Implications for Finance and Accounting Teams

KPMG

10:20

Networking and Refreshment Break

10:30

LUMINARY SEGMENT
Disruption and Technology Innovation within Healthcare and Finance

MODERATED BY:

Tim Gordon
Global FAAS Life Sciences Leader
Ernst & Young LLP

12:50

Networking Luncheon

Hosted by:

1:50 CHOOSE BETWEEN 4 CONCURRENT WORKSHOPS (A-D)

WORKSHOP A Credit Losses —
Standard Changes and Implementation Considerations

Erik Bradbury
Partner, Financial Accounting Advisory Services
Ernst & Young LLP

WORKSHOP B Corporate Tax Reform Implications

Benjamin Proce
New York Metro Pharma and Life Sciences Tax Leader
PwC

Kathleen Michael
US Health Industries Tax Leader
PwC

WORKSHOP C M&A and Licensing — The Art and Science of Valuations

Andreas Chrysostomou
Managing Director, Global Leader – Healthcare Life Sciences Industry
Duff & Phelps

WORKSHOP D Digital Technologies, Automation and
Advanced Analytics in Finance

Brad Schulte
Senior Manager, Life Sciences Advisory Services
Deloitte & Touche LLP

Alex Smith
Partner
Deloitte & Touche LLP

2:40

Networking and Refreshment Break
Hosted by

3:10 CHOOSE BETWEEN 4 CONCURRENT WORKSHOPS (E-H)

WORKSHOP E Lease Accounting — ASC 842 Implementation

Christopher Nyers
Partner
CFGI

WORKSHOP F GTN Models and Frameworks

Michael Makovec
Partner
Deloitte & Touche LLP

WORKSHOP G Capital Allocation and R&D Portfolio Optimization

Lisa Banker
Partner/Principal, Northeast Life Sciences Transactions Market Leader
Ernst & Young LLP

WORKSHOP H Accounting for Collaborations

Kelly MacDonald
Senior Director, Financial Planning and Analysis
Ironwood Pharmaceuticals

Tim Kocses
Director, Corporate Technical Accounting
Bristol-Myers Squibb Company

4:00

Coffee Break

4:20 CHOOSE BETWEEN 3 CONCURRENT WORKSHOPS (I-K)

WORKSHOP I Business Transformation and Next-Generation Finance

Candice Cantelli Meklis
Vice President
Archetype

WORKSHOP J Divestitures and Portfolio Optimization Strategies

Mitesh Maheshwari
Executive Director, Americas Financial Accounting Advisory
Ernst & Young LLP

Subin Baral
Life Sciences Transactions Partner
Ernst & Young LLP

WORKSHOP K Payer Negotiations for Improved Profitability —
A Role Play Exercise

Murray Kay
Trainer; former SVP and CEO, Solvay Pharmaceuticals;
former Commercial Controller, AbbVie & Abbott Laboratories

5:20

CLOSE OF WORKSHOPS AND DAY TWO

Please Join Us for a Cocktail Reception Immediately Following the Close of Workshops HOSTED BY: Deloitte

DAY THREE FRIDAY MARCH 22, 2018

7:15

Breakfast

T R A C K E D   P R O G R A M M I N G

8:40 CHOOSE BETWEEN 3 CONCURRENT CONTENT TRACKS (I-III)

TRACK I LARGE COMPANY SESSIONS

TRACK CHAIR:

Dennis Howell
Partner
Deloitte & Touche LLP

8:15

Track Chairperson’s Opening Remarks

8:30

OPENING LEADERSHIP PANEL Accounting and SEC Reporting Hot Topics — Key Considerations for
Corporate Controllers and Chief Accountants in the Year Ahead

MODERATOR:

Ryan Dolan
Partner
CFGI

PANELISTS:

Kevin MacKay
Vice President, Controller and Chief Accounting Officer
Pfizer

James D’Arreca
Senior Vice President and Chief Accounting Officer
Allergan plc

Gisele Dion
Senior Vice President, Chief Accounting Officer and Controller
Shire

Stephen Rivera
Vice President, Global Technical Accounting Advisory Services and Policy
Johnson & Johnson

9:15

PANELCritical Audit Matters — A Look at the New Auditor’s Report and
Key Implications for Corporate Preparers

MODERATOR:

Jeff Ellis
Partner, U.S. Life Sciences and Healthcare Audit Leader
Deloitte & Touche LLP

PANELISTS:

Matt Busch
Executive Director, Corporate Accounting
Amgen

Sabrina Basu
External Reporting, Technical Accounting and Internal Controls
Ironwood Pharmaceuticals

10:00

Networking and Refreshment Break

10:30

Leases —
Next Steps to Optimize Organizational Processes and Systems for ASC842

Melissa Bird
Senior Manager, FAAS
Ernst & Young LLP

Kevin MacKay
Vice President, Controller and Chief Accounting Officer
Pfizer

11:15

Technology-Enabled Carve-Outs and Divestitures

Shurjo K. Sen
Deals Partner
PwC

Robert Owens
Vice President and Chief Accountant
BMS

TRACK II EMERGING COMPANY SESSIONS

TRACK CHAIR:

Brian Jobe
Partner
Deloitte & Touche LLP

8:15

Track Chairperson’s Opening Remarks

8:30

OPENING LEADERSHIP PANEL Scaling for Growth and Taking a Company Commercial —
Pearls of Wisdom from CFOs

MODERATOR:

William Roberts
Partner
Ernst & Young LLP

PANELISTS:

Rhonda Chicko
Chief Financial Officer
Scholar Rock

Chad Cohen
Chief Financial Officer
Adaptive Biotechnologies

9:15

Strategies for Middle Market Companies to Succeed in an Ultra-Competitive Marketplace — Leadership, Governance and Stakeholder Engagement

Todd Berry
Assurance Partner and National Co-Leader, Life Sciences
BDO USA LLP

Tom Ziemba, Ph.D.
Managing Director
BDO USA LLP

10:00

Networking and Refreshment Break

10:30

PANELCapital Creation, Success Runways and Strategic Resource Allocation for
Early Stage Companies

MODERATOR:

Moderator TBA

PANELISTS:

Ted Myles
Executive Vice President and Chief Financial Officer
AMAG Pharmaceuticals, Inc.

Dominic Piscitelli
Chief Financial Officer
AnaptysBio

Stephen Garbacz
Senior Vice President of Finance and Operations
Spero Therapeutics

11:15

Managing Third-Party Oversight and Mitigating Risks with Service Provider Relationships

Speaker TBA

TRACK III DEVICE AND HEALTH TECH SESSIONS

TRACK CHAIR:

PwC

8:15

Track Chairperson’s Opening Remarks

8:30

OPENING LEADERSHIP PANELKey Accounting and Financial Reporting Matters —
Practical Strategies and Insights for Device Companies

MODERATOR:

John Sichak
Partner
PwC

PANELISTS:

Thomas Spoerel
Vice President of Finance and Controller
BD

Emily Collins
Director, Technical Accounting and SEC Reporting
Boston Scientific

Mary Wilcox
Chief Accounting Officer
Medtronic

9:15

Tax Strategies and Related Issues for Medical Device Companies

Speaker TBA

10:00

Networking and Refreshment Break

10:30

Complying with the EU MDR Regulations —
Strategies for Finance and Accounting Executives

Caroline West
Global Chief Compliance Officer
Olympus Corporation (Invited)

11:15

Innovations, M&A, Evolution and Disruption in the Health Tech Market

Peter Micca
Partner, Life Sciences and Healthcare
Deloitte & Touche LLP(Invited)

12:00 CLOSE OF TRACKS AND NETWORKING LUNCHEON

1:50 CLOSING SYMPOSIA (A-B)

A Automation and Blockchain — Impact to Forecasting, Financial Planning and Other Processes

Mathew Harrowing
Senior Manager, FAAS – Digital Growth Platform Leader
Ernst & Young LLP

Rick Capasso
Executive Director, Americas Financial Accounting Advisory Services
Ernst & Young LLP

B The Future Workforce — Strategies to Empower the Team, Elevate Talent and Cultivate a Winning Culture

Randy Brown
Principal
PwC Advisory

Marla Graeber
Principal, Health Industries People and Change Practice Leader
PwC

2:00

Close of Congress

Agenda

Want more agenda details? Download the brochure.

Want more agenda details? Download the brochure.

DAY ONE WEDNESDAY, MARCH 20, 2019

9:00

Pre-Congress Registration

10:00 CHOOSE FROM 3 PRE-CONGRESS BREAKOUT SESSIONS (I-III)

I 101 Boot Camp

Michael Lombardo
Partner
Deloitte & Touche LLP

II New Product Commercialization/ Launch Strategies

Graham Poles
Partner
PwC

Zachary Weisbly
Director
PwC

Manmeet S. Soni
Chief Financial Officer
Alnylam Pharmaceuticals, Inc.

Chris Prentiss
Chief Accounting Officer
Adamas Pharmaceuticals, Inc.

III Industry-Only Roundtable Session

Nancy Stempin
Executive Director, Financial Accounting Advisory Services
Ernst & Young LLP

10:45

Networking and Refreshment Break

12:00

General Registration

1:00 CHOOSE BETWEEN 2 NETWORKING SUMMITS (A-B)

A Newcomer’s Orientation and Welcome Summit

SUMMIT DISCUSSION LEADERS:

James D’Arreca
Senior Vice President and Chief Accounting Officer
Allergan plc

Robert Owens
Vice President and Chief Accountant
BMS

Stephen Rivera
Vice President, Global Technical Accounting Advisory Services and Policy
Johnson & Johnson

B Women’s Leadership Summit

SUMMIT DISCUSSION LEADERS:

Laura Robinette
US Pharmaceutical and Life Sciences Assurance Leader
PwC

Toni Lockett Cromwell
Partner
PwC

DISCUSSION CONTRIBUTORS:

Gisele Dion
Senior Vice President, Chief Accounting Officer and Controller
Shire

Jill McConnell
Chief Financial Officer
Covance

Cynthia Schwalm
retired CEO, Ipsen;
current Biotech Board Member

Jennifer Ziolkowski
Chief Financial Officer
Solid Biosciences

2:00

Networking and Refreshment Break

GENERAL SESSION

2:30

Chairperson’s Welcoming Remarks

Cathy Engelbert
CEO
Deloitte

2:45

CEO Fireside Chat — Candid Conversation on Key Business and Industry Topics

Cathy Engelbert
CEO
Deloitte

Heather Bresch
CEO
Mylan

3:30

CFO KEYNOTE PANELLeading in Finance and Navigating the Course of Change

MODERATOR:

Laura Robinette
US Pharmaceutical and Life Sciences Assurance Leader
PwC

PANELISTS:

Blaise Coleman
Chief Financial Officer
Endo

Bryan Reasons
Chief Financial Officer
Impax Labs/Amneal

Paolo Tombesi
Chief Financial Officer
Insmed Incorporated

Mark W Hahn
Chief Financial Officer
Dova Pharmaceuticals, Inc.

4:30

REGULATORY INSIGHTS PANEL Making Strides in the Relevance and Effectiveness of Financial Reporting

MODERATOR:

Christine Davine
Partner and National Director of SEC Services
Deloitte & Touche LLP

PANELISTS:

James G. Kaiser
Board Member
PCAOB

Sagar Teotia
Deputy Chief Accountant
U.S. Securities and Exchange Commission

5:15

Industry Spotlight —
SEC Insights and Comment Letter Reviews of Life Science and Health Companies

James Rosenberg
Senior Assistant Chief Accountant, Office of Health Care and Insurance
U.S. Securities and Exchange Commission

Christine Davine
Partner and National Director of SEC Services
Deloitte & Touche LLP

5:40

Close of Day One

JOIN US FOR THE OPENING NIGHT WELCOME RECEPTION immediately following the final session on day one HOSTED BY: Ernst & Young

DAY TWO THURSDAY, MARCH 21, 2019

6:00

“Rocky Run”   Hosted by: PwC

Join PwC and industry colleagues in a morning “Rocky Run”. Participants depart the hotel at 6am and run just under 2 miles to the Philadelphia Art Museum, ascending the famous Rocky Steps and taking a photo with Rocky’s statue. Do not miss this traditional Philadelphia right of passage! Return transportation provided.

7:00

Breakfast

8:00

Co-Chairs’ Welcome and Opening Remarks

Jeff Ellis
Partner, U.S. Life Sciences and Healthcare Audit Leader
Deloitte & Touche LLP

8:15

WALL STREET AND INVESTMENT PANELImpactful Deals and Breakthroughs Impacting the Life Science Marketplace

MODERATER:

Pamela Yanakopulos
Partner, Capital Market and Accounting Advisory
PwC

PANELISTS:

Tony Gibney
Executive Vice President and Chief Business Officer
Achillion Pharmaceuticals, Inc.

Jeffrey Schwartz
Managing Director, Life Sciences
Bain Capital

Speaker to be announced
Bank of America Merrill Lynch

9:00

Pricing, Reimbursement and Outcomes-Based Contracting Models —
An Inflection Point of Change for Today’s Life Science Landscape

Susan Garfield
Global Advisory Principal and Life Sciences Sector Commercial Lead
Ernst & Young LLP

Sasha Richardson
Executive Director – Advisory Lifesciences, Commercial Strategy
Ernst & Young LLP

9:40

Value-Based Healthcare and Implications for Finance and Accounting Teams

KPMG

10:20

Networking and Refreshment Break

10:30

LUMINARY SEGMENT
Disruption and Technology Innovation within Healthcare and Finance

MODERATED BY:

Tim Gordon
Global FAAS Life Sciences Leader
Ernst & Young LLP

12:50

Networking Luncheon

Hosted by:

1:50 CHOOSE BETWEEN 4 CONCURRENT WORKSHOPS (A-D)

WORKSHOP A Credit Losses —
Standard Changes and Implementation Considerations

Erik Bradbury
Partner, Financial Accounting Advisory Services
Ernst & Young LLP

WORKSHOP B Corporate Tax Reform Implications

Benjamin Proce
New York Metro Pharma and Life Sciences Tax Leader
PwC

Kathleen Michael
US Health Industries Tax Leader
PwC

WORKSHOP C M&A and Licensing — The Art and Science of Valuations

Andreas Chrysostomou
Managing Director, Global Leader – Healthcare Life Sciences Industry
Duff & Phelps

WORKSHOP D Digital Technologies, Automation and
Advanced Analytics in Finance

Brad Schulte
Senior Manager, Life Sciences Advisory Services
Deloitte & Touche LLP

Alex Smith
Partner
Deloitte & Touche LLP

2:40

Networking and Refreshment Break
Hosted by

3:10 CHOOSE BETWEEN 4 CONCURRENT WORKSHOPS (E-H)

WORKSHOP E Lease Accounting — ASC 842 Implementation

Christopher Nyers
Partner
CFGI

WORKSHOP F GTN Models and Frameworks

Michael Makovec
Partner
Deloitte & Touche LLP

WORKSHOP G Capital Allocation and R&D Portfolio Optimization

Lisa Banker
Partner/Principal, Northeast Life Sciences Transactions Market Leader
Ernst & Young LLP

WORKSHOP H Accounting for Collaborations

Kelly MacDonald
Senior Director, Financial Planning and Analysis
Ironwood Pharmaceuticals

Tim Kocses
Director, Corporate Technical Accounting
Bristol-Myers Squibb Company

4:00

Coffee Break

4:20 CHOOSE BETWEEN 3 CONCURRENT WORKSHOPS (I-K)

WORKSHOP I Business Transformation and Next-Generation Finance

Candice Cantelli Meklis
Vice President
Archetype

WORKSHOP J Divestitures and Portfolio Optimization Strategies

Mitesh Maheshwari
Executive Director, Americas Financial Accounting Advisory
Ernst & Young LLP

Subin Baral
Life Sciences Transactions Partner
Ernst & Young LLP

WORKSHOP K Payer Negotiations for Improved Profitability —
A Role Play Exercise

Murray Kay
Trainer; former SVP and CEO, Solvay Pharmaceuticals;
former Commercial Controller, AbbVie & Abbott Laboratories

5:20

CLOSE OF WORKSHOPS AND DAY TWO

Please Join Us for a Cocktail Reception Immediately Following the Close of Workshops HOSTED BY: Deloitte

DAY THREE FRIDAY MARCH 22, 2018

7:15

Breakfast

T R A C K E D   P R O G R A M M I N G

8:40 CHOOSE BETWEEN 3 CONCURRENT CONTENT TRACKS (I-III)

TRACK I LARGE COMPANY SESSIONS

TRACK CHAIR:

Dennis Howell
Partner
Deloitte & Touche LLP

8:15

Track Chairperson’s Opening Remarks

8:30

OPENING LEADERSHIP PANEL Accounting and SEC Reporting Hot Topics — Key Considerations for
Corporate Controllers and Chief Accountants in the Year Ahead

MODERATOR:

Ryan Dolan
Partner
CFGI

PANELISTS:

Kevin MacKay
Vice President, Controller and Chief Accounting Officer
Pfizer

James D’Arreca
Senior Vice President and Chief Accounting Officer
Allergan plc

Gisele Dion
Senior Vice President, Chief Accounting Officer and Controller
Shire

Stephen Rivera
Vice President, Global Technical Accounting Advisory Services and Policy
Johnson & Johnson

9:15

PANELCritical Audit Matters — A Look at the New Auditor’s Report and
Key Implications for Corporate Preparers

MODERATOR:

Jeff Ellis
Partner, U.S. Life Sciences and Healthcare Audit Leader
Deloitte & Touche LLP

PANELISTS:

Matt Busch
Executive Director, Corporate Accounting
Amgen

Sabrina Basu
External Reporting, Technical Accounting and Internal Controls
Ironwood Pharmaceuticals

10:00

Networking and Refreshment Break

10:30

Leases —
Next Steps to Optimize Organizational Processes and Systems for ASC842

Melissa Bird
Senior Manager, FAAS
Ernst & Young LLP

Kevin MacKay
Vice President, Controller and Chief Accounting Officer
Pfizer

11:15

Technology-Enabled Carve-Outs and Divestitures

Shurjo K. Sen
Deals Partner
PwC

Robert Owens
Vice President and Chief Accountant
BMS

TRACK II EMERGING COMPANY SESSIONS

TRACK CHAIR:

Brian Jobe
Partner
Deloitte & Touche LLP

8:15

Track Chairperson’s Opening Remarks

8:30

OPENING LEADERSHIP PANEL Scaling for Growth and Taking a Company Commercial —
Pearls of Wisdom from CFOs

MODERATOR:

William Roberts
Partner
Ernst & Young LLP

PANELISTS:

Rhonda Chicko
Chief Financial Officer
Scholar Rock

Chad Cohen
Chief Financial Officer
Adaptive Biotechnologies

9:15

Strategies for Middle Market Companies to Succeed in an Ultra-Competitive Marketplace — Leadership, Governance and Stakeholder Engagement

Todd Berry
Assurance Partner and National Co-Leader, Life Sciences
BDO USA LLP

Tom Ziemba, Ph.D.
Managing Director
BDO USA LLP

10:00

Networking and Refreshment Break

10:30

PANELCapital Creation, Success Runways and Strategic Resource Allocation for
Early Stage Companies

MODERATOR:

Moderator TBA

PANELISTS:

Ted Myles
Executive Vice President and Chief Financial Officer
AMAG Pharmaceuticals, Inc.

Dominic Piscitelli
Chief Financial Officer
AnaptysBio

Stephen Garbacz
Senior Vice President of Finance and Operations
Spero Therapeutics

11:15

Managing Third-Party Oversight and Mitigating Risks with Service Provider Relationships

Speaker TBA

TRACK III DEVICE AND HEALTH TECH SESSIONS

TRACK CHAIR:

PwC

8:15

Track Chairperson’s Opening Remarks

8:30

OPENING LEADERSHIP PANELKey Accounting and Financial Reporting Matters —
Practical Strategies and Insights for Device Companies

MODERATOR:

John Sichak
Partner
PwC

PANELISTS:

Thomas Spoerel
Vice President of Finance and Controller
BD

Emily Collins
Director, Technical Accounting and SEC Reporting
Boston Scientific

Mary Wilcox
Chief Accounting Officer
Medtronic

9:15

Tax Strategies and Related Issues for Medical Device Companies

Speaker TBA

10:00

Networking and Refreshment Break

10:30

Complying with the EU MDR Regulations —
Strategies for Finance and Accounting Executives

Caroline West
Global Chief Compliance Officer
Olympus Corporation (Invited)

11:15

Innovations, M&A, Evolution and Disruption in the Health Tech Market

Peter Micca
Partner, Life Sciences and Healthcare
Deloitte & Touche LLP(Invited)

12:00 CLOSE OF TRACKS AND NETWORKING LUNCHEON

1:50 CLOSING SYMPOSIA (A-B)

A Automation and Blockchain — Impact to Forecasting, Financial Planning and Other Processes

Mathew Harrowing
Senior Manager, FAAS – Digital Growth Platform Leader
Ernst & Young LLP

Rick Capasso
Executive Director, Americas Financial Accounting Advisory Services
Ernst & Young LLP

B The Future Workforce — Strategies to Empower the Team, Elevate Talent and Cultivate a Winning Culture

Randy Brown
Principal
PwC Advisory

Marla Graeber
Principal, Health Industries People and Change Practice Leader
PwC

2:00

Close of Congress